Research & Data

Addiction & Recovery Statistics 2026

The most comprehensive collection of addiction prevalence, mortality, treatment effectiveness, and recovery outcome statistics. All cited from peer-reviewed research and federal health agencies.

Last updated: August 2026 · Sources: SAMHSA, NIDA, CDC, NIH, peer-reviewed journals

Table of Contents

  1. Addiction Prevalence in the United States
  2. Overdose & Mortality Statistics
  3. Treatment Access & Effectiveness
  4. Opioid Crisis Statistics
  5. Alcohol Use Disorder Statistics
  6. Stimulant Addiction Statistics
  7. Behavioral Addiction Statistics
  8. Recovery Outcomes
  9. Withdrawal & Detox Statistics
  10. Digital Health & App-Based Recovery
Section 1

Addiction Prevalence in the United States

How common is addiction? The national scope of substance use disorders.

48.7M
Americans with a substance use disorder in the past year
SAMHSA NSDUH, 2023
17.3%
of Americans aged 12+ meet SUD criteria
SAMHSA NSDUH, 2023
29.5M
Americans with alcohol use disorder
SAMHSA NSDUH, 2023
6.1M
Americans with opioid use disorder
SAMHSA NSDUH, 2023
Section 2

Overdose & Mortality Statistics

The human cost of addiction, deaths, hospitalizations, and the fentanyl era.

107,500
drug overdose deaths in the U.S. in 2023
CDC NCHS, 2024
73%
of overdose deaths involving synthetic opioids (primarily fentanyl)
CDC, 2023
95,000
alcohol-related deaths per year in the U.S.
CDC, 2023
#1
Drug overdose is the leading cause of accidental death in the U.S.
CDC, 2023
  • Drug overdose deaths increased by 278% between 1999 and 2021 (from 16,849 to 106,699). CDC NCHS
  • Illicitly manufactured fentanyl accounted for approximately 73% of all overdose deaths in 2023, up from less than 1% in 2010. CDC 2024
  • Stimulant involvement (meth and cocaine) was present in approximately 32% of overdose deaths, often in combination with opioids. CDC 2023
  • Alcohol-attributable deaths account for approximately 95,000 deaths annually in the U.S., about 261 deaths per day. CDC Alcohol-Related Disease Impact application
  • Tobacco kills approximately 480,000 Americans per year, making it the leading cause of preventable death in the U.S. CDC, 2023
  • Overdose deaths among people 35–44 increased by over 300% from 2010–2022. CDC NCHS
  • Fatal overdose risk is highest in the first 4 weeks after release from incarceration (29× higher than the general population). Binswanger et al. NEJM, 2007
  • Fatal overdose risk is also elevated in the first 2 weeks after hospital discharge for opioid-related events. Larochelle et al. NEJM, 2018
  • Globally, alcohol causes approximately 3 million deaths per year, 5.3% of all deaths. WHO, Global Status Report on Alcohol and Health, 2022

Why overdose risk spikes after quitting: When a person stops using opioids, their tolerance drops rapidly, often within days. If they relapse, the dose that was previously tolerated can now be fatal. This is why the period immediately after detox or leaving treatment is the highest-risk window.

Section 3

Treatment Access & Effectiveness

What works, what doesn't reach people, and the treatment gap.

6.3%
of people with SUD who received treatment in the past year
SAMHSA NSDUH 2023
50–70%
reduction in opioid mortality with MAT (buprenorphine or methadone)
Sordo et al. BMJ 2017
40–60%
addiction relapse rate, comparable to other chronic diseases
NIDA
<20%
of people with opioid use disorder who receive any FDA-approved medication
SAMHSA 2022
Section 4

Opioid Crisis Statistics

Fentanyl, heroin, prescription opioids, the numbers behind the deadliest addiction crisis in U.S. history.

6.1M
Americans with opioid use disorder
SAMHSA 2023
78,000+
opioid overdose deaths in the U.S. in 2023
CDC 2024
$1.02T
annual economic cost of the opioid crisis in the U.S.
Florence et al. Drug & Alcohol Dependence, 2021
80%
of heroin users began with prescription opioids
NIDA, 2020
  • Fentanyl is approximately 50–100× more potent than morphine and 25–50× more potent than heroin by weight. DEA, 2022
  • A lethal dose of fentanyl is approximately 2 milligrams, equivalent to a few grains of salt. DEA, 2022
  • Approximately 80% of people who use heroin first misused prescription opioids. NIDA, Prescription Drug Abuse, 2020
  • Neonatal Opioid Withdrawal Syndrome (NOWS) affects approximately 1 infant every 15 minutes born in the United States. CDC, 2023
  • Buprenorphine reduces risk of overdose death by 65% but fewer than 20% of people with OUD receive it. Larochelle et al. NEJM 2018, SAMHSA 2022
  • The average time from first opioid use to overdose death is approximately 10–15 years. Various, including NIDA longitudinal data
  • Fentanyl test strips can detect fentanyl in drug supplies with 96% sensitivity. Sherman et al. Harm Reduction Journal, 2018
Section 5

Alcohol Use Disorder Statistics

The most prevalent substance use disorder in the U.S., by a significant margin.

29.5M
Americans with alcohol use disorder
SAMHSA 2023
95,000
alcohol-attributable deaths in the U.S. per year
CDC 2023
2–3
only withdrawals that can be directly fatal (alcohol & benzos)
Clinical standard
8%
of people with AUD who receive any treatment in a given year
SAMHSA 2022
Section 6

Stimulant Addiction Statistics

Meth, cocaine, and the rise of polysubstance overdose.

2.7M
Americans used methamphetamine in the past year
SAMHSA 2023
5.1M
Americans used cocaine in the past year
SAMHSA 2023
32%
of U.S. overdose deaths involve stimulants
CDC 2023
0
FDA-approved medications for meth or cocaine use disorder (as of 2026)
NIDA
  • Methamphetamine is approximately 3–5× more potent than cocaine and produces a longer high (8–24 hours vs 20–90 minutes). NIDA, 2019
  • Meth-involved overdose deaths increased by 180% between 2015 and 2021, driven largely by contamination with fentanyl. CDC, 2022
  • Contingency Management (CM), rewarding abstinence with vouchers or prizes, is the most evidence-supported treatment for stimulant use disorder. Prendergast et al. Addiction, 2006
  • CM produces 6-month abstinence rates of approximately 30–40% in stimulant use disorder. Petry et al. Journal of Consulting and Clinical Psychology, 2004
  • Cocaine withdrawal does not produce the severe physical symptoms of opioid or alcohol withdrawal, but psychological withdrawal (depression, anhedonia, cravings) can be severe for weeks. Gawin & Kleber, Archives of General Psychiatry, 1986
Section 7

Behavioral Addiction Statistics

Gaming, shopping, gambling, porn, work, the non-substance addictions.

Gambling Disorder

  • 1–3% of U.S. adults meet criteria for gambling disorder NIDA
  • ~5–10 million Americans affected
  • Suicide risk 3–4× higher in problem gamblers Newman & Thompson, 2003
  • CBT produces 60–80% short-term improvement rates Pallesen et al. 2005

Gaming Disorder

  • 3–4% of gamers estimated to meet WHO ICD-11 criteria WHO, 2019
  • Formally recognized by WHO in 2019 (ICD-11)
  • fMRI studies show dopamine pathway changes comparable to substance addiction Kuss & Griffiths, 2012
  • Higher rates in adolescent males (8.5%) Lemmens et al. 2009

Compulsive Buying Disorder

  • 5–6% prevalence in general population Müller et al. 2019
  • Higher prevalence online (up to 8.3%) Andreassen et al. 2015
  • Dopamine spikes during anticipation, not ownership
  • Comorbid with anxiety (57%) and depression (54%) Black, CNS Spectrums, 2007

Work Addiction (Workaholism)

  • 10–14% of workers meet criteria for workaholism Andreassen et al. 2016
  • Associated with 20–30% higher burnout rates Clark et al. 2016
  • Workaholics report lower relationship satisfaction despite higher income Robinson, 2014
  • ACT most evidence-supported treatment Hayes et al.
Section 8

Recovery Outcomes

The hopeful data, recovery is common, measurable, and increasingly well-understood.

75%
of people with addiction eventually achieve stable remission
SAMHSA, 2020
72.2%
of U.S. adults who ever had SUD are now in recovery
AJP, 2022
90 days
threshold where measurable dopamine D2 receptor recovery appears on fMRI
Volkow et al. NIDA
5 years
after which relapse risk approaches that of the general population
NIDA longitudinal research
  • Recovery from addiction is common: SAMHSA estimates approximately 20.3 million U.S. adults are in recovery from a substance use disorder. SAMHSA, 2020
  • Relapse rates for addiction (40–60%) are comparable to relapse rates for hypertension (50–70%) and asthma (50–70%), supporting addiction's classification as a chronic disease. McLellan et al. JAMA, 2000
  • The longer a person maintains abstinence, the lower their relapse risk: people with 4–5 years of sobriety have relapse rates similar to the general population. NIDA
  • Social support is the strongest predictor of long-term recovery outcomes, more predictive than treatment type. Kelly et al. Journal of Substance Abuse Treatment, 2017
  • Employment is associated with 20–40% better recovery outcomes at 1 year. McLellan et al. Drug and Alcohol Dependence, 1994
  • 12-step program (AA/NA) participation is associated with 20–30% higher rates of sustained abstinence at 1 year compared to no peer support. Kelly et al. Cochrane Review, 2020
  • People who use digital health tools (apps, online communities) for addiction recovery show 15–25% better engagement and retention than those without digital support. Tofighi et al. Substance Abuse Treatment, Prevention, and Policy, 2019
  • Mindfulness-Based Relapse Prevention (MBRP) reduces substance use at 4 months post-treatment by 54% compared to treatment as usual. Bowen et al. Journal of Consulting and Clinical Psychology, 2009
Section 9

Withdrawal & Detox Statistics

What the research says about withdrawal timelines, severity, and medical risk.

Section 10

Digital Health & App-Based Recovery

The evidence base for technology-assisted addiction recovery.

15–25%
better recovery engagement with digital health tools vs. no digital support
Tofighi et al. 2019
3x
more likely to stay in treatment with regular digital check-in vs. monthly clinic visit only
Campbell et al. 2014
23%
reduction in alcohol consumption with app-based CBT over 3 months
Gustafson et al. JAMA, 2014
94M
Americans who need addiction treatment but don't receive it, the addressable gap for digital health
SAMHSA NSDUH 2023
  • The CHESS mobile app (Comprehensive Health Enhancement Support System) reduced days of heavy drinking by 50% compared to standard care in a randomized controlled trial. Gustafson et al. JAMA Internal Medicine, 2014
  • Recovery support services delivered via smartphone show 80% user retention at 30 days in preliminary studies, compared to 30–50% retention in traditional outpatient programs. Various, including Quanbeck et al. 2014
  • 84% of people with substance use disorders own a smartphone, digital health tools can reach populations that traditional treatment cannot. Tofighi et al. Substance Abuse Treatment, Prevention, and Policy, 2019
  • Ecological momentary assessment (EMA) via smartphone can predict craving and relapse risk 1–3 hours before occurrence with 75% accuracy. Serre et al. Drug and Alcohol Dependence, 2015
  • Just-in-time adaptive interventions (JITAIs), app-delivered support triggered by high-risk moments, are associated with 20–40% reductions in craving intensity. Nahum-Shani et al. Annual Review of Clinical Psychology, 2018
  • Peer support communities in recovery apps are associated with 30% better 90-day sobriety rates compared to apps without community features. Kelly et al. Journal of Substance Abuse Treatment, 2017

Primary Sources

  1. SAMHSA. (2023). National Survey on Drug Use and Health (NSDUH). Substance Abuse and Mental Health Services Administration.
  2. CDC. (2024). Drug Overdose Deaths in the United States, 2023. Centers for Disease Control and Prevention, National Center for Health Statistics.
  3. NIDA. (2021). Drugs, Brains, and Behavior: The Science of Addiction. National Institute on Drug Abuse.
  4. Sordo L, et al. (2017). Mortality risk during and after opioid substitution treatment. BMJ, 357, j1550.
  5. Larochelle MR, et al. (2018). Medication for Opioid Use Disorder after Nonfatal Opioid Overdose. New England Journal of Medicine, 378(23), 2194–2201.
  6. Mattick RP, et al. (2020). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews.
  7. McLellan AT, et al. (2000). Drug dependence, a chronic medical illness. JAMA, 284(13), 1689–1695.
  8. Kelly JF, et al. (2020). Alcoholics Anonymous and other 12-step programs for alcohol use disorder. Cochrane Database of Systematic Reviews.
  9. Gustafson DH, et al. (2014). A smartphone application to support recovery from alcoholism. JAMA Internal Medicine, 174(7), 1014–1022.
  10. WHO. (2022). Global Status Report on Alcohol and Health. World Health Organization.
  11. Florence CS, et al. (2021). The economic burden of opioid use disorder and fatal opioid overdose in the United States. Drug and Alcohol Dependence, 218, 108350.
  12. Müller A, et al. (2019). Prevalence of compulsive buying in psychiatric outpatient settings. Journal of Behavioral Addictions.
  13. Andreassen CS, et al. (2016). The Bergen Work Addiction Scale. Scandinavian Journal of Psychology.

Use our free recovery tools:

Savings Calculator Sobriety Counter Withdrawal Calculator

Ready to start your recovery?

Forge tracks your sobriety streak, delivers an AI coach personalized to your addiction type, and provides crisis support when cravings hit hardest.

Download Forge Free →